Search results for "Valga"

showing 9 items of 9 documents

Monitoring of Trough Plasma Ganciclovir Levels and Peripheral Blood Cytomegalovirus (CMV)-Specific CD8 + T Cells To Predict CMV DNAemia Clearance in …

2014

ABSTRACT It is uncertain whether monitoring plasma ganciclovir (GCV) levels is useful in predicting cytomegalovirus (CMV) DNAemia clearance in preemptively treated allogeneic stem cell transplant recipients. In this observational study, including 13 episodes of CMV DNAemia treated with intravenous (i.v.) GCV or oral valganciclovir, we showed that monitoring trough plasma GCV levels does not reliably predict response to therapy. Rather, immunological monitoring (pp65 and immediate-early [IE]-1-specific gamma interferon [IFN-γ]-producing CD8 + T cells) appeared to perform better for this purpose.

AdultMaleGanciclovirvirusesCongenital cytomegalovirus infectionCytomegalovirusCD8-Positive T-LymphocytesClinical TherapeuticsViral Matrix ProteinsInterferon-gammamedicineHumansValganciclovirCytotoxic T cellPharmacology (medical)GanciclovirMultiple myelomaPharmacologybusiness.industryLymphoma Non-HodgkinAnemia Aplasticvirus diseasesValganciclovirMiddle AgedPrecursor Cell Lymphoblastic Leukemia-LymphomaPhosphoproteinsmedicine.diseaseTransplant RecipientsLeukemia Myeloid AcuteLeukemiaInfectious DiseasesCytomegalovirus InfectionsDNA ViralImmunologyFemaleStem cellMultiple MyelomabusinessCD8Stem Cell Transplantationmedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients.

2015

Background This study aimed to characterize the dynamics of acquisition of cytomegalovirus (CMV)-specific cell-mediated immunity (CMI) in CMV donor positive/recipient negative solid organ transplant (SOT) patients receiving long-term antiviral prophylaxis, and to determine whether development of CMI confers protection against CMV disease. Methods A prospective multicenter study was conducted in Spain from September 2009 to September 2012. Whole blood specimens were prospectively collected at 30, 90, 120, 200, and 365 days after SOT, and CMI was determined by enumeration of CMV pp65 and IE-1-specific CD69+/interferon-γ-producing CD8+ and CD4+ T cells by flow cytometry for intracellular cytok…

AdultMalemedicine.medical_specialtyCongenital cytomegalovirus infectionCytomegalovirusDiseaseKaplan-Meier EstimateGastroenterologyAntiviral AgentsPostoperative ComplicationsImmunityInternal medicinemedicineHumansValganciclovirProspective StudiesGanciclovirSurvival analysisAgedPostoperative CareTransplantationImmunity Cellularbusiness.industryIncidence (epidemiology)Organ TransplantationMiddle Agedmedicine.diseaseTransplantationClinical trialInfectious DiseasesTreatment OutcomeImmunologyCytomegalovirus InfectionsFemalebusinessCD8Follow-Up StudiesTransplant infectious disease : an official journal of the Transplantation Society
researchProduct

Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice

2015

Producción Científica

AdultMalemedicine.medical_specialtyRiñones - TrasplanteCongenital cytomegalovirus infectionCytomegaloviruskidney transplantationSIDA (Enfermedad)Kaplan-Meier EstimateDiseaseAntiviral AgentsAsymptomaticRisk FactorsInternal medicineseropositive recipientpreemptive therapymedicineHumansValganciclovirProspective StudiesRenal InsufficiencyPropensity ScoreGanciclovircytomegalovirusKidney transplantationAgedProportional Hazards ModelsTransplantation3205.06 Nefrologíabusiness.industryProportional hazards modelIncidenceIncidence (epidemiology)antiviral prophylaxisMiddle Agedmedicine.diseaseKidney TransplantationDiscontinuationSurgerymulticenter studySpainCytomegalovirus InfectionsPropensity score matchingFemalemedicine.symptombusinessImmunosuppressive AgentsGlomerular Filtration Rate
researchProduct

Dvīņu pilsētu-Valkas un Valgas-pārrobežu sadarbība

2017

Kopš Šengenas zonas paplašināšanās Eiropas Savienības dalībvalstu robežu funkcijas ir mainījušās. Ir attīstījušās jaunas politiskās sadarbības formas starp nacionālajām robežām, un robežas kļuvušas atvērtākas. Maģistra darba mērķis ir noskaidrot un novērtēt līdzšinējo pārrobežu sadarbību starp dvīņu pilsētām uz Latvijas un Igaunijas robežas un atklāt aspektus, kas abām dvīņu pilsētām savā pārrobežu sadarbībā būtu jāuzlabo. Lai sasniegtu maģistra darba mērķi, tika izvirzīti vairāki uzdevumi, tostarp izpētīt pārrobežu sadarbību starp dvīņu pilsētām – Valku un Valgu, noskaidrot pārrobežu sadarbības labos piemērus un problēmas, kā arī izstrādāt priekšlikumus Valkas un Valgas pārrobežu sadarbība…

Baltijas jūras reģiona studijasrobežas šķērsošanadvīņu pilsētasValgapārrobežu sadarbībaValka
researchProduct

DI-032 Study of effectiveness and safety of foscarnet in cytomegalovirus treatment in haematopoietic stem cell transplantation recipients

2016

Background Cytomegalovirus disease is an important cause of morbidity and mortality in haematopoietic stem cell transplantation (HSCT) recipients. Foscarnet, an intravenous drug active against cytomegalovirus, represents an increasingly widespread alternative when there is resistance or intolerance to conventional treatments (ganciclovir/valganciclovir, acyclovir). More data about its use, effectiveness and safety in the clinical practice are necessary. Purpose To analyse the effectiveness and safety of the use of foscarnet against cytomegalovirus in HSCT recipients, and its adaptation to clinical practice guidelines and expert recommendations in order to optimise future treatment strategie…

GanciclovirFoscarnetmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCongenital cytomegalovirus infectionvirus diseasesValganciclovirHematopoietic stem cell transplantationmedicine.diseaseSurgeryTransplantationInternal medicinemedicineGeneral Pharmacology Toxicology and PharmaceuticsbusinessAdverse effectViral loadmedicine.drugEuropean Journal of Hospital Pharmacy
researchProduct

Early postoperative recurrence of severe crohnʼs disease, with colonic involvement and associated human cytomegalovirus infection, treated with oral …

2011

Human cytomegalovirusCrohn's diseasemedicine.medical_specialtySettore MED/09 - Medicina Internabusiness.industrypostoperative crohncolonic involvementhuman cytomegalovirus infection valgancicloviradalimumabGastroenterologyValganciclovirmedicine.diseaseGastroenterologyInternal medicineImmunologymedicineAdalimumabImmunology and Allergybusinessmedicine.drugInflammatory Bowel Diseases
researchProduct

2020

Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in liver transplant recipients, but their toxicity needs to be balanced against the benefits. The choice of prevention strategy (prophylaxis or preemptive treatment) depends on the donor/recipient sero-status but may vary between institutions. We conducted a series of consultations and roundtable discussions with German liver transplant center representatives. Based on 20 out of 22 centers, we herein summarize the current approaches to CMV prevention and treatment in the context of liver transplantation in Germany. In 90…

Human cytomegalovirusGanciclovirmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentvirus diseasesValganciclovirContext (language use)ImmunosuppressionViremiaGeneral Medicine030230 surgeryLiver transplantationmedicine.disease3. Good health03 medical and health sciences0302 clinical medicineCurrent practiceInternal medicinemedicine030211 gastroenterology & hepatologybusinessmedicine.drugJournal of Clinical Medicine
researchProduct

II Cavalgada de l'any nou xinés 2013

2013

segona cavalcada per a celebrar l'entrada del nou any xinés 2013

any nou xinès año nuevo chino cavalgada cabalgata Instituto confucio
researchProduct

Orejas valgas: estabilización mediante colgajo dermo-graso-pericóndrico retroauricular

2013

El tratamiento quirúrgico para la corrección de las orejas prominentes o valgas se basa en crear una distancia de entre 17-21 mm entre el hélix y la mastoides, así como recrear unos pliegues auriculares anteriores bien definidos. Desde finales de 1800 hasta la actualidad se han descrito muchas técnicas para corregir las orejas despegadas, prominentes o valgas, cada una de ellas con sus propias características. En el presente trabajo describimos una técnica para estabilizar el resultado quirúrgico cuando se corrige esta entidad y evitar su recidiva. Se trata de un procedimiento de fijación mastoidea de la oreja mediante un colgajo dermo-graso-pericóndrico de sencillo diseño, útil, seguro y f…

musculoskeletal diseasesPhysicsOtoplastiabiologyAnatomymusculoskeletal systembiology.organism_classificationOrejas prominentesbody regionsValgusOrejas en asaHelixotorhinolaryngologic diseasesSurgerysense organsOrejas valgasCirugía Plástica Ibero-Latinoamericana
researchProduct